Thursday, August 15, 2019

CBI’s 5th Edition Drug Pricing Transparency Congress

CBI’s 5th Edition Drug Pricing Transparency Congress
September 18-19, 2019 | Sheraton University City | Philadelphia, PA
www.cbinet.com/DrugPricing

With the recent regulatory activity surrounding drug pricing transparency, bio/pharma manufacturers must continuously be ahead of the ever-evolving changes. Stay on the pulse of Federal and State reporting requirements, policy initiatives and strategic best practices for implementation at the 5th Edition Drug Pricing Transparency Congress taking place September 18-19 in Philadelphia.

Exclusive Offer for Drug Channels Readers:
Register Now to SAVE $300* using promo code DRG300

This meeting’s agenda provides timely and mission-critical updates on how drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices, with an expert speaking faculty including those representing PhRMA, Sanofi, King & Spalding, Celgene, BIO, Boehringer Ingelheim, Sidley Austin, Pfizer, Mallinckrodt and more!

High Impact Topics Transforming Pricing Dynamics Include:
  • Anticipate New State Legislations to Watch in 2020 — A Practical Analysis
  • State Drug Pricing Transparency Level-Set — Reporting and Requirements Landscape
  • Status Update on Federal Initiatives for Transparency
  • State-by-State Analysis Showcase
  • Industry Talk — Set up an Internal Team to Respond to Drug Pricing Transparency Laws
  • PLUS! Choose Between Two Pre-Conference Workshops
    • A. Drug Pricing Transparency Bootcamp — Key Considerations and Learnings For Reporting
    • B. Strategize for 2020 — Breaking Down Transparency Headlines for Industry
Visit cbinet.com/DrugPricing to view the complete speaker and in-depth session lineup, then register using promo code DRG300 for this exclusive savings of $300 off!*

*Discount expires 9/17/19; cannot be combined or applied to existing registration. Other restrictions may apply.


The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...